Revolution Medicines Completes Acquisition of EQRx
Benzinga
NOVEMBER 9, 2023
Billion in Net Cash to Revolution Medicines' Balance Sheet, Supporting Late-Stage Development of RAS(ON) Inhibitor Investigational Drugs Sandra Horning, M.D., Joins Revolution Medicines' Board of Directors REDWOOD CITY, Calif., 09, 2023 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.
Let's personalize your content